These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 5288250)

  • 1. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
    Deleña S; Brown H
    Metabolism; 1969 Nov; 18(11):901-5. PubMed ID: 5350555
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.
    Miyagi K; Cardinal R; Bossenmaier I; Watson CJ
    J Lab Clin Med; 1971 Nov; 78(5):683-95. PubMed ID: 5128821
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyrin synthesis in drug induced hepatic porphyria.
    Rao MR; Padmanaban G; Sarma PS
    Biochem Pharmacol; 1971 Aug; 20(8):2001-7. PubMed ID: 5137957
    [No Abstract]   [Full Text] [Related]  

  • 7. Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias.
    Watson CJ; Pierach CA; Bossenmaier I; Cardinal R
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2118-20. PubMed ID: 266732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.
    Watson CJ; Bossenmaier I; Cardinal R; Petryka ZJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):278-82. PubMed ID: 4521800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematin treatment of acute intermittent porphyria. A case report (author's transl)].
    Marchiori PE; de Assis JL; Scaff M; Do Serro-Azul LG; Moraes EC; Bacheschi LA; Yassuda N
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):325-33. PubMed ID: 531276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Atchison WD; Peterson RE
    Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria].
    KELENYI G; ARATO G; BUDA V; ORBAN S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906
    [No Abstract]   [Full Text] [Related]  

  • 13. The measurement of the synthetic rate of bilirubin from hepatic hemes in patients with acute intermittent porphyria.
    Jones EA; Bloomer JR; Berlin NI
    J Clin Invest; 1971 Nov; 50(11):2259-65. PubMed ID: 5096511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hematin in hepatic porphyria. Further studies.
    Dhar GJ; Bossenmaier I; Petryka ZJ; Cardinal R; Watson CJ
    Ann Intern Med; 1975 Jul; 83(1):20-30. PubMed ID: 1147435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hematin in acute porphyric relapse.
    Watson CJ; Dhar GJ; Bossenmaier I; Cardinal R; Petryka ZJ
    Ann Intern Med; 1973 Jul; 79(1):80-3. PubMed ID: 4721179
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 17. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute attacks of hepatic porphyria. Treatment with hematin. 5 cases].
    Devars du Mayne JF; Deybach JC; Phung L; Likforman J; Tenhunen R; Cerf M; Nordmann Y
    Presse Med; 1986 Oct; 15(33):1673-6. PubMed ID: 2947113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of delta-aminolaevulinic acid and porphobilinogen in human erythrocytes in acute intermittent porphyria.
    Doss M
    Enzyme; 1973; 16(1):343-53. PubMed ID: 4791053
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria.
    Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP
    Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.